Myocardial spet imaging with 99Tcm-tetrofosmin in clinical practice comparison of a 1 day and a 2 day imaging protocol

Nuclear Medicine Communications

Volumn 18, Issue 1, 1997, Pages 24-30

  Van Eck Smit, B L F ^a   Pauwels, E K J ^a   Poots, S ^a   Van Der Wall, E E ^a   Bruschke, A V G ^a   Zwinderman, A H ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

TETROFOSMIN TC 99M;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CORONARY ARTERY DISEASE; FEMALE; HEART MUSCLE ISCHEMIA; HEART SCINTISCANNING; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0031038923     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1080/00006231-199701000-00006     Document Type: Article

References (26)

1. Zaret BL, Wackers FJ. Nuclear cardiology (medical progress) Part I. N Engl J Med 1993; 329: 775-783.
2. Strauss HW, Harrison K, Langan JK, Lebowitz E, Pitt B. Thallium-201 for myocardial imaging: relation of thallium-201 to regional myocardial perfusion. Circulation 1975; 51: 641-645.
3. Wackers F, Berman D, Maddahi J et al. Technetium-99m hexakis-2-methoxyisobutyl isonitrile: Human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 for myocardial perfusion imaging. J Nucl Med 1989; 30: 301-311.
4. Leppo JA, DePuey EG, Johnson LL. A review of cardiac imaging with sestamibi and teboroxime. J Nucl Med 1991; 32: 2012-2020.
5. Beller GA, Watson DD. Physiological basis of myocardial perfusion imaging with technetium-99m agents. Sent Nucl Med 1991; 21: 173-181.
6. Gibbons RJ. Technetium-99m sestamibi in the assessment of acute myocardial infarction. Sent Nucl Med 1991; 21: 213-222.
7. mTc 2-methoxy-isobutyl-isonitrile: A direct comparison in normal individuals and patients with coronary artery disease. Circulation 1989; 79: 1282-1293.
8. Seldin DW, Johnson LL, Blood DK et al. Myocardial perfusion imaging with technetium-99m SQ30,217: Comparison with thallium-201 and coronary anatomy. J Nucl Med 1989; 30: 312-319.
9. Hendel RC, McSherry, Karimeddini M, Leppo JA. Diagnostic value of new myocardial perfusion agent, teboroxime (SQ 30127), utilizing a rapid planar imaging protocol: Preliminary results. J Am Coll Cardiol 1990; 16: 855-861.
10. Kelley JD, Forster AM, Higley B et al. Technetium-99m-tetrofosmin as a new radiopharmaceutical for myocardial perfusion imaging. J Nucl Med 1993; 34: 222-227.
11. Higley B, Smith FW, Gemmel HG et al. Technetium-99m-1,2 bis[bis(2-ethoxyethyl)phosphino] ethane: Human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent. J Nucl Med 1992; 34: 30-38.
12. Tamaki N, Takahashi N, Kawamoto M et al. Myocardial tomography using technetium-99m-tetrofosmin to evaluate coronary artery disease. J Nucl Med 1994; 35: 594-600.
13. Rigo P, Leclercq, Itti R, Lahiri A, Braat S. Technetium-99m-tetrofosmin myocardial imaging: A comparison with thallium-201 and angiography. J Nucl Med 1994; 35: 587-593.
14. Heo J, Cave V, Wasserleben V, Iskandrian AS. Planar and tomographic imaging with technetium 99m-labeled tetro-fosmin: Correlation with thallium 201 and coronary angiography. J Nucl Cardiol 1994; 1: 317-324.
15. Zaret BL, Rigo P, Wackers FJ et al. Myocardial perfusion imaging with 99mTc tetrofosmin: Comparison to 201T1 imaging and coronary angiography in a Phase II multicenter trial. Circulation 1995; 91: 313-319.
16. Hendel RC, Parker MA, Wackers FJT et al. Reduced variability of interpretation and improved image quality with a technetium 99m myocardial perfusion agent: Comparison of thallium 201 and technetium 99m-labeled tetrofosmin. J Nucl Cardiol 1994; 1: 509-514.
17. Jain D, Wackers FJT, Mattera J, McMahon M, Sinusas AJ, Zaret BL. Biokinetics of technetium-99m-tetrofosmin: Myocardial perfusion imaging agent. Implications for a one-day imaging protocol. J Nucl Med 1993; 34: 1254-1259.
18. m-tetrofosmin as a myocardial perfusion agent in routine clinical use. Nucl Med Commun 1995; 16: 733-740.
19. Braat SH, Leclercq B, Itti R, Lahiri A, Sridhara B, Rigo P. Myocardial imaging with technetium-99m-tetrofosmin: Comparison of one-day and two-day protocols. J Nucl Med 1994; 35: 1581-1585.
20. Sridhara B, Sochor H, Rigo P et al. Single-photon emission computed tomographic imaging with technetium-99m tetrofosmin: Stress-rest imaging with same-day and separate-day rest imaging. J Nucl Cardiol 1994; 1: 138-143.
21. Liang K-Y, Zeger SL, Qaqish B. Multivariate regression analyses for categorical data. JRSS 1992; B54: 3-40.
22. Nakajima K, Taki J, Shuke N, Bunko H, Takata S, Hisada K. Myocardial perfusion imaging and dynamic analysis with technetium-99m tetrofosmin. J Nucl Med 1993; 34: 1478-1484.
23. Au Yong TK, Chambers J, Maisey NM, Fogelman I, Clarke ESM. Technetium-99m tetrofosmin myocardial perfusion scan: Comparison of 1-day and 2-day protocols. Eur J Nucl Med 1996; 23: 320-325.
24. Mahmood S, Gunning JB, Bomanji JB et al. Combined rest thallium-201/stress technetium-99m tetrofosmin SPECT: Feasibility and diagnostic accuracy of a 90-minute protocol. J Nucl Med 1995; 36: 932-935.
25. Takahashi N, Tamaki N, Tadamura E et al. Combined assessment of regional perfusion and wall motion in patients with coronary artery disease with technetium 99m tetrofosmin. J Nucl Cardiol 1994; 1: 29-38.
26. m-tetrofosmin. Nucl Med Commun 1996; 17: 669-674.